An allograft is tissue that is transplanted from one person to another. Soft tissue allografts are an important substitute tissue for the reconstruction of deficient ligaments, torn menisci, and osteochondral defects during knee surgery. Interest in allografts for soft tissue reconstruction has arisen from the demand to obtain a stable knee with restoration of function and protection against additional injury. Gen Consulting Company predicts that the global soft tissue allografts market is estimated to touch a valuation of USD 6,688 million, registering a CAGR of 5.7% during the forecast period (2022-2028).
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global soft tissue allografts market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the soft tissue allografts industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for soft tissue allografts can be segmented by product: amniotic allografts, cartilage allografts, dental allografts, meniscus allografts, tendon allografts, others. According to the research, the cartilage allografts segment had the largest share in the global soft tissue allografts market. Soft tissue allografts market is further segmented by application: dentistry, orthopedic, wound care, others. In 2021, the dentistry segment made up the largest share of revenue generated by the soft tissue allografts market. Based on end user, the soft tissue allografts market is segmented into: hospitals, aesthetic centers, clinics, others. On the basis of region, the soft tissue allografts market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.
By product:
- amniotic allografts
- cartilage allografts
- dental allografts
- meniscus allografts
- tendon allografts
- others
By application:
- dentistry
- orthopedic
- wound care
- others
By end user:
- hospitals
- aesthetic centers
- clinics
- others
By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
The report also provides analysis of the key companies of the industry and their detailed company profiles including Allosource Inc., Arthrex Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Johnson & Johnson, MiMedx Group Inc., Organogenesis, Inc., SeaSpine Holdings Corporation, Straumann Holding AG, Zimmer Biomet Holdings, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global soft tissue allografts market.
- To classify and forecast the global soft tissue allografts market based on product, application, end user, region.
- To identify drivers and challenges for the global soft tissue allografts market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global soft tissue allografts market.
- To identify and analyze the profile of leading players operating in the global soft tissue allografts market.
Why Choose This Report
- Gain a reliable outlook of the global soft tissue allografts market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Amniotic allografts
· Cartilage allografts
· Dental allografts
· Meniscus allografts
· Tendon allografts
· Others
PART 6. MARKET BREAKDOWN BY APPLICATION
· Dentistry
· Orthopedic
· Wound care
· Others
PART 7. MARKET BREAKDOWN BY END USER
· Hospitals
· Aesthetic centers
· Clinics
· Others
PART 8. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 9. KEY COMPANIES
· Allosource Inc.
· Arthrex Inc.
· Globus Medical, Inc.
· Integra LifeSciences Corporation
· Johnson & Johnson
· MiMedx Group Inc.
· Organogenesis, Inc.
· SeaSpine Holdings Corporation
· Straumann Holding AG
· Zimmer Biomet Holdings, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Market Overview
The Asia Pacific Integrated Facility Management Market is projected for substantial growth from 2024 to 2034. Valued at USD XX.XX billion in 2024, the market is anticipated to reach USD XX.XX billion by 2034, reflecting a robust compound annual growth rate (CAGR) of XX.X...
Market Overview
The Europe Integrated Facility Management Market is anticipated to witness robust growth from 2024 to 2034, driven by increasing demand for streamlined operations, cost efficiencies, and enhanced workplace experiences. The market is expected to reach a valuation of USD X...
Market Overview
The North America Integrated Facility Management (IFM) Market is projected to experience significant growth from 2024 to 2034, driven by the increasing demand for comprehensive facility management solutions across various industries. As organizations seek to optimize ope...
Market Overview
The Global Integrated Facility Management (IFM) Market is projected to experience robust growth from 2024 to 2034, driven by the increasing demand for streamlined and efficient facility management solutions. Integrated Facility Management encompasses the coordination of ...
Market Overview
The Asia Pacific Facility Management Market is poised for substantial growth from 2024 to 2034, driven by the increasing complexity of facility operations and the rising demand for integrated management solutions. The market is expected to reach USD XX.XX billion by 2034...
Market Overview
The Europe Facility Management Market is set to experience substantial growth from 2024 to 2034, driven by increasing demand for efficient management services across various industries. The market is projected to reach USD XX.XX billion by 2034, growing at a compound ann...
Market Overview
The North America Facility Management Market is poised for significant growth between 2024 and 2034, driven by increasing demand for efficient management solutions across various sectors. By 2034, the market is expected to reach USD XX.XX billion, up from USD XXX.XX bill...
Market Overview
The Global Facility Management Market is projected to witness significant growth from 2024 to 2034, driven by the increasing complexity of business operations and the need for efficient management of facilities. Valued at USD XX.XX billion in 2024, the market is expected...
Market Overview
The Asia Pacific Active Protection Systems Market is poised for significant growth from 2024 to 2034. This growth is driven by the escalating security threats, technological advancements in defense systems, and the increasing investments by governments in modernizing the...
Market Overview
The Europe Active Protection Systems Market is expected to witness substantial growth over the next decade, driven by increasing defense expenditure, technological advancements in protection systems, and growing security threats. The market is projected to reach a valuat...